Research Department, Cytos Biotechnology, CH-8952 Zurich-Schlieren, Switzerland.
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20566-71. doi: 10.1073/pnas.1206970109. Epub 2012 Nov 20.
The lung is an important entry site for pathogens; its exposure to antigens results in systemic as well as local IgA and IgG antibodies. Here we show that intranasal administration of virus-like particles (VLPs) results in splenic B-cell responses with strong local germinal-center formation. Surprisingly, VLPs were not transported from the lung to the spleen in a free form but by B cells. The interaction between VLPs and B cells was initiated in the lung and occurred independently of complement receptor 2 and Fcγ receptors, but was dependent upon B-cell receptors. Thus, B cells passing through the lungs bind VLPs via their B-cell receptors and deliver them to local B cells within the splenic B-cell follicle. This process is fundamentally different from delivery of blood or lymph borne particulate antigens, which are transported into B cell follicles by binding to complement receptors on B cells.
肺是病原体的重要进入部位;它暴露于抗原会导致全身和局部 IgA 和 IgG 抗体产生。在这里,我们表明,鼻内给予病毒样颗粒 (VLPs) 会导致脾脏 B 细胞产生强烈的局部生发中心形成反应。令人惊讶的是,VLPs 并没有以游离形式从肺部运输到脾脏,而是通过 B 细胞运输。VLPs 与 B 细胞之间的相互作用是在肺部开始的,并且独立于补体受体 2 和 Fcγ 受体,但依赖于 B 细胞受体。因此,穿过肺部的 B 细胞通过其 B 细胞受体结合 VLPs,并将其递送至脾脏 B 细胞滤泡内的局部 B 细胞。这个过程与通过结合 B 细胞上的补体受体将血液或淋巴携带的颗粒性抗原递送至 B 细胞滤泡中的过程有根本的不同。